Most cited article(s)

Clinical/Scientific Notes
Guillain-Barré syndrome related to COVID-19 infection
Paola Alberti, Simone Beretta, Marco Piatti, et al.

April 29, 2020
Article
Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic diseaseMore to come with myositis in the offing
Marinos C. Dalakas

June 09, 2020
Article
Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
Alberto Vogrig, Marine Fouret, Bastien Joubert, et al.

August 07, 2019
Article
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
Patrick Waters, Mark Woodhall, Kevin C. O'Connor, et al.

March 19, 2015
Article
Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient
Tania Cellucci, Heather Van Mater, Francesc Graus, et al.

January 17, 2020
Article
Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
Hadas Stiebel-Kalish, Mark Andrew Hellmann, Michael Mimouni, et al.

May 21, 2019
Article
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
Francesc Graus, Alberto Vogrig, Sergio Muñiz-Castrillo, et al.

May 18, 2021
Article
Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
Sung-Min Kim, Mark R. Woodhall, Ji-Sun Kim, et al.

October 15, 2015
Article
Rituximab before and during pregnancyA systematic review, and a case series in MS and NMOSD
Gitanjali Das, Vincent Damotte, Jeffrey M. Gelfand, et al.

March 19, 2018
Article
International multicenter examination of MOG antibody assays
Markus Reindl, Kathrin Schanda, Mark Woodhall, et al.

February 05, 2020

Pages